Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Coordinated immune dysregulation in juvenile dermatomyositis revealed by single-cell genomics
Gabrielle Rabadam, Camilla Wibrand, Emily Flynn, George C. Hartoularos, Yang Sun, Chioma Madubata, Gabriela K. Fragiadakis, Chun Jimmie Ye, Susan Kim, Zev J. Gartner, Marina Sirota, Jessica Neely
Gabrielle Rabadam, Camilla Wibrand, Emily Flynn, George C. Hartoularos, Yang Sun, Chioma Madubata, Gabriela K. Fragiadakis, Chun Jimmie Ye, Susan Kim, Zev J. Gartner, Marina Sirota, Jessica Neely
View: Text | PDF
Research Article

Coordinated immune dysregulation in juvenile dermatomyositis revealed by single-cell genomics

  • Text
  • PDF
Abstract

Juvenile dermatomyositis (JDM) is one of several childhood-onset autoimmune disorders characterized by a type I IFN response and autoantibodies. Treatment options are limited due to an incomplete understanding of how the disease emerges from dysregulated cell states across the immune system. We therefore investigated the blood of patients with JDM at different stages of disease activity using single-cell transcriptomics paired with surface protein expression. By immunophenotyping peripheral blood mononuclear cells, we observed skewing of the B cell compartment toward an immature naive state as a hallmark of JDM at diagnosis. Furthermore, we find that these changes in B cells are paralleled by T cell signatures suggestive of Th2-mediated inflammation that persist despite disease quiescence. We applied network analysis to reveal that hyperactivation of the type I IFN response in all immune populations is coordinated with previously masked cell states including dysfunctional protein processing in CD4+ T cells and regulation of cell death programming in NK cells, CD8+ T cells, and γδ T cells. Together, these findings unveil the coordinated immune dysregulation underpinning JDM and provide insight into strategies for restoring balance in immune function.

Authors

Gabrielle Rabadam, Camilla Wibrand, Emily Flynn, George C. Hartoularos, Yang Sun, Chioma Madubata, Gabriela K. Fragiadakis, Chun Jimmie Ye, Susan Kim, Zev J. Gartner, Marina Sirota, Jessica Neely

×

Figure 7

Disease activity in JDM is associated with central hub of IFN response in network, correlated with dysregulated immune cell states.

Options: View larger image (or click on image) Download as PowerPoint
Disease activity in JDM is associated with central hub of IFN response i...
(A) Network graph showing results of 4-group 1-way ANOVA of each program’s expression, with node size scaled according to P value and colored according to strength of the association between disease status and program expression. (B) Heatmap showing significant differences in expression of selected disease activity–associated programs between HC (n = 5) and patients with inactive JDM (n = 6), active JDM (n = 7), and TNJDM (n = 9). Columns are annotated by P values of case-control t test and disease activity association (4-group 1-way ANOVA). (C and D) Selected network modules colored by FDR of enrichment for indicated gene ontology set (FDR < 0.01) or gene loading similarity within Modules 2 (C) and 5 (D).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts